HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March
Shares of Nasdaq-listed HealthEquity fell 2.9% to $95.64 in afternoon trade on Friday after Goldman Sachs cut its rating to sell from neutral and set an $89 price target. The stock hit a session low of $92.97 before it pared some of the drop.